Breakwater Capital Group
Source: SEC Form 13F · as of Mar 2026Breakwater Capital Group holds 19 biotech & pharma companies tracked by BioSniper, totaling $15.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$15.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 2,737 | $2.5M |
| PFEPFIZER INC | 68,126 | $1.9M |
| JNJJOHNSON & JOHNSON | 6,741 | $1.6M |
| MRKMerck & Co., Inc. | 12,415 | $1.5M |
| ABBVAbbVie Inc. | 6,280 | $1.4M |
| DGXQuest Diagnostics Incorporated | 5,480 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,962 | $876K |
| AMGNAMGEN INC | 2,039 | $717K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,412 | $653K |
| AZNASTRAZENECA PLC | 2,897 | $571K |
| ABTABBOTT LABORATORIES | 4,699 | $482K |
| MCKMcKesson Corporation | 469 | $406K |
| IQVIQVIA Holdings Inc. | 2,009 | $343K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,007 | $333K |
| PMPhilip Morris International Inc | 1,850 | $306K |
| DNLIDenali Therapeutics Inc. | 15,586 | $299K |
| CYTKCYTOKINETICS INC | 3,941 | $260K |
| BMYBRISTOL MYERS SQUIBB CO | 4,158 | $252K |
| RXRXRECURSION PHARMACEUTICALS, INC. | 17,472 | $54K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.